MEASUREMENT OF ANTIPYRINE HALF-LIFE FROM URINARY DRUG CONCENTRATIONS

被引:10
作者
TAYLOR, G [1 ]
BLASCHKE, TF [1 ]
机构
[1] UWIST,WELSH SCH PHARM,CARDIFF CF1 3XF,WALES
关键词
D O I
10.1111/j.1365-2125.1984.tb02524.x
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:650 / 652
页数:3
相关论文
共 8 条
[1]   ASSAY OF ANTIPYRINE AND ITS PRIMARY METABOLITES IN PLASMA, SALIVA AND URINE BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND SOME PRELIMINARY-RESULTS IN MAN [J].
DANHOF, M ;
GROOTVANDERVIS, ED ;
BREIMER, DD .
PHARMACOLOGY, 1979, 18 (04) :210-223
[2]   STUDIES ON THE DIFFERENT METABOLIC PATHWAYS OF ANTIPYRINE IN MAN .1. ORAL-ADMINISTRATION OF 250, 500 AND 1000 MG TO HEALTHY-VOLUNTEERS [J].
DANHOF, M ;
BREIMER, DD .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 8 (06) :529-537
[3]   ANTIPYRINE METABOLISM IN RELATION TO POLYMORPHIC OXIDATIONS OF SPARTEINE AND DEBRISOQUINE [J].
EICHELBAUM, M ;
BERTILSSON, L ;
SAWE, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 15 (03) :317-321
[4]   ASSESSMENT OF ANTIPYRINE KINETICS BY MEASUREMENT IN SALIVA [J].
FRASER, HS ;
MUCKLOW, JC ;
MURRAY, S ;
DAVIES, DS .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 3 (02) :321-325
[5]   DRUG URINARY EXCRETION DATA - SOME ASPECTS CONCERNING INTERPRETATION [J].
MARTIN, BK .
BRITISH JOURNAL OF PHARMACOLOGY AND CHEMOTHERAPY, 1967, 29 (02) :181-&
[6]   DIFFERENTIAL INDUCTION OF ANTIPYRINE METABOLISM BY RIFAMPICIN [J].
TOVERUD, EL ;
BOOBIS, AR ;
BRODIE, MJ ;
MURRAY, S ;
BENNETT, PN ;
WHITMARSH, V ;
DAVIES, DS .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1981, 21 (02) :155-160
[7]  
VESSELL ES, 1975, CLIN PHARMACOL THER, V18, P259
[8]  
WELCH RM, 1975, CLIN PHARMACOL THER, V18, P249